Goldman Sachs analyst Akinori Ueda upgraded Chugai Pharmaceutical (4519:JP) from Neutral to Buy with a price target of JPY8,950.00.The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE